Transmedics
TMDX
178 hedge funds and large institutions have $1.18B invested in Transmedics in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 18 closing their positions.
250% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 18
68% more call options, than puts
Call options by funds: $24.1M | Put options by funds: $14.4M
64% more capital invested
Capital invested by funds: $720M → $1.18B (+$462M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
33% more funds holding
Funds holding: 134 → 178 (+44)
20% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 44
8.73% more ownership
Funds ownership: 81.73% → 90.46% (+8.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$33.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$33.6M |
| 3 |
FAM
Fred Alger Management
New York
|
+$19M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$16.6M |
| 5 |
OAM
Ophir Asset Management
Sydney,
Australia
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$14.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.2M |
| 3 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
-$10.6M |
| 4 |
Millennium Management
New York
|
-$7.12M |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$6.52M |
TMDX Hedge Fund Activity: Q3 2022 in Review
178 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q3 2022, worth a combined $1.18B — up 64% from $720M a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new TMDX positions and 18 closed out — a net gain of 45 holders — while 53 added to existing stakes and 44 trimmed.
The largest buyer was Summit Partners Public Asset Management, adding an estimated $33.6M. The largest seller was Credit Suisse, cutting an estimated $14.1M.
- 178 institutional investors held Transmedics (TMDX) as of Q3 2022, up from 134 in Q2 2022.
- Funds reported $1.18B of Transmedics stock for Q3 2022, up 64% quarter-over-quarter.
- 63 funds opened new Transmedics positions in Q3 2022 and 18 closed out, a net change of +45 holders.
- The largest Transmedics buyer in Q3 2022 was Summit Partners Public Asset Management, an estimated $33.6M added.
- The largest Transmedics seller in Q3 2022 was Credit Suisse, an estimated $14.1M sold.
Based on aggregated 13F filings for Q3 2022.